Skip to main content
Supplement ScienceSupplementScience

GABA Side Effects & Safety

Evidence:Emerging
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Safety Profile

Overall safety rating: Generally Safe

Potential Side Effects

  • Generally well tolerated at standard doses
  • Mild tingling or flushing sensation (transient, harmless)
  • Drowsiness at higher doses
  • Mild shortness of breath sensation at very high doses (rare)
  • Headache (rare)

Drug & Supplement Interactions

  • Benzodiazepines and GABAergic medications — potential additive sedation
  • Blood pressure medications — GABA may mildly lower blood pressure
  • Antiepileptic drugs — theoretical interaction via GABAergic pathways
  • Alcohol — additive CNS depressant effects

Maximum Dose

Do not exceed: 750mg/day (limited safety data above this level)

Full GABA Guide

References

  1. RCTAbdou AM, Higashiguchi S, Horie K, Kim M, Hatta H, Yokogoshi H (2006). Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. BioFactors. DOI PubMed
  2. RCTNakamura H, Takishima T, Kometani T, Yokogoshi H (2009). Psychological stress-reducing effect of chocolate enriched with gamma-aminobutyric acid (GABA) in humans. International Journal of Food Sciences and Nutrition. DOI PubMed
  3. Meta-analysisGodfrey K, Douglass H, Erritzoe D, Muthukumaraswamy S, et al. (2025). The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysis.. Progress in neuro-psychopharmacology & biological psychiatry. DOI PubMed
  4. Meta-analysisPasanta D, He JL, Ford T, Oeltzschner G, et al. (2023). Functional MRS studies of GABA and glutamate/Glx - A systematic review and meta-analysis.. Neuroscience and biobehavioral reviews. DOI PubMed
  5. Meta-analysisSimmonite M, Steeby CJ, Taylor SF (2023). Medial Frontal Cortex GABA Concentrations in Psychosis Spectrum and Mood Disorders: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.. Biological psychiatry. DOI PubMed
  6. Kumar V, Vajawat B, Rao NP (2021). Frontal GABA in schizophrenia: A meta-analysis of 1H-MRS studies.. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. DOI PubMed
  7. Porges EC, Jensen G, Foster B, Edden RA, et al. (2021). The trajectory of cortical GABA across the lifespan, an individual participant data meta-analysis of edited MRS studies.. eLife. DOI PubMed
Show 2 more references
  1. Kantrowitz JT, Dong Z, Milak MS, Rashid R, et al. (2021). Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder.. Translational psychiatry. DOI PubMed
  2. Sydnor VJ, Roalf DR (2020). A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk.. Schizophrenia research. DOI PubMed